Is it time to retire efavirenz as a first-line option worldwide? Guanira JV, Fichtenbaum CJ. AIDS 2022;36:317-318.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guanira JV, Fichtenbaum CJ. Is it time to retire efavirenz as a first-line option worldwide? AIDS 2022;36:317-318.
PMID: 34934022